Haemonetics Corp. (HAE) Ownership

$60.59

$0.04 (-0.07%)
Last update: 04:23 PM EST
Day's range
$59.8
Day's range
$61.06

Haemonetics Corp. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 5.82 M $466.55 M   -3.32% 12.44%
VANGUARD GROUP INC 01/29/2026 4.76 M $381.60 B   -1.52% 10.18%
NEUBERGER BERMAN GROUP LLC 02/13/2026 3.87 M $309.88 M   5.32% 8.26%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 3.16 M $253.52 M   48.58% 6.76%
STATE STREET CORP 02/13/2026 1.73 M $138.65 M   -3.94% 3.70%
CITADEL ADVISORS LLC 02/17/2026 1.29 M $103.27 B   481.87% 2.75%
GOLDMAN SACHS GROUP INC 02/10/2026 1.23 M $98.31 B   110.49% 2.62%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.19 M $95.76 B   -0.73% 2.55%
NORTH PEAK CAPITAL MANAGEMENT, LLC 02/13/2026 1.10 M $88.40 M   204.39% 2.36%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.09 M $87.60 M   -0.60% 2.34%
ROYAL BANK OF CANADA 02/17/2026 967.59 K $77.55 M   -23.26% 2.07%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 939.73 K $75.16 M   -11.41% 2.01%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 01/13/2026 717.00 K $57.47 M   1.51% 1.53%
BOSTON TRUST WALDEN CORP 01/28/2026 580.65 K $46.54 M   -39.31% 1.24%
CITIGROUP INC 02/13/2026 569.17 K $45.62 M   32.66% 1.22%
MORGAN STANLEY 02/13/2026 562.95 K $45.12 M   8.09% 1.20%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 548.92 K $44.00 M   -2.29% 1.17%
UBS GROUP AG 01/29/2026 539.68 K $43.26 M   -62.85% 1.15%
JANE STREET GROUP, LLC 02/12/2026 526.29 K $42.18 B   85.48% 1.12%
BARROW HANLEY MEWHINNEY & STRAUSS LLC 02/11/2026 523.11 K $41.93 M   -6.58% 1.12%
BANK OF AMERICA CORP /DE/ 02/17/2026 482.17 K $38.65 B   44.23% 1.03%
FRANKLIN RESOURCES INC 02/11/2026 464.10 K $37.20 M   -26.01% 0.99%
MARSHALL WACE, LLP 02/13/2026 432.96 K $34.70 M   -6.65% 0.93%
DEUTSCHE BANK AG\ 02/11/2026 401.76 K $32.20 M   38.77% 0.86%
ARISTOTLE CAPITAL BOSTON, LLC 02/17/2026 370.31 K $29.68 M   -8.38% 0.79%
BOSTON PARTNERS 02/13/2026 322.67 K $25.77 M   -43.48% 0.69%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 02/09/2026 314.65 K $25.22 M   -33.99% 0.67%
BANK OF NEW YORK MELLON CORP 02/10/2026 305.22 K $24.46 M   -12.82% 0.65%
MIZUHO MARKETS AMERICAS LLC 02/06/2026 278.31 K $22.31 M   110.34% 0.59%
MIZUHO MARKETS AMERICAS LLC 02/06/2026 278.31 K $271.24 K   100.00% 0.59%
JPMORGAN CHASE & CO 02/11/2026 256.55 K $20.56 M   -8.04% 0.55%
NUVEEN, LLC 02/12/2026 234.58 K $18.80 M   75.98% 0.50%
CITIGROUP INC 02/13/2026 220.00 K $17.63 M   100.00% 0.47%
RAYMOND JAMES FINANCIAL INC 02/18/2026 168.32 K $13.49 M   -48.10% 0.36%
SEI INVESTMENTS CO 02/13/2026 167.36 K $13.41 M   -0.15% 0.36%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 163.78 K $13.13 M   10.45% 0.35%
LOOMIS SAYLES & CO L P 02/12/2026 154.25 K $12.36 M   -31.24% 0.33%
RHUMBLINE ADVISERS 02/13/2026 140.41 K $11.25 B   -10.50% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 133.20 K $10.68 M   -7.56% 0.28%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 131.56 K $10.54 M   -0.31% 0.28%
NORGES BANK 02/10/2026 125.93 K $10.09 M   100.00% 0.27%
GOLDMAN SACHS GROUP INC 02/10/2026 125.20 K $10.03 B   100.00% 0.27%
BARCLAYS PLC 02/13/2026 124.23 K $9.96 M   4.12% 0.27%
HRT FINANCIAL LP 02/12/2026 115.87 K $9.29 M   225.20% 0.25%
PEAK6 LLC 02/13/2026 108.20 K $8.67 M   100.00% 0.23%
KESTREL INVESTMENT MANAGEMENT CORP 02/03/2026 98.10 K $7.86 M   -3.63% 0.21%
NORDEA INVESTMENT MANAGEMENT AB 01/08/2026 95.26 K $7.62 M   -11.66% 0.20%
SWISS NATIONAL BANK 02/12/2026 95.00 K $7.61 M   2.04% 0.20%
WELLS FARGO & COMPANY/MN 02/13/2026 91.12 K $7.30 M   75.74% 0.19%
CAMPBELL & CO INVESTMENT ADVISER LLC 02/12/2026 86.90 K $6.96 M   1,167.26% 0.19%

Haemonetics Corp. institutional Ownership - FAQ's

During the previous two years, 422 institutional investors and hedge funds held shares of Haemonetics Corp.. The most heavily invested institutionals were:

BlackRock, Inc.: 5.82 M

VANGUARD GROUP INC: 4.76 M

Neuberger Berman Group LLC: 3.87 M

AQR CAPITAL MANAGEMENT LLC: 3.16 M

STATE STREET CORP: 1.73 M

CITADEL ADVISORS LLC: 1.29 M

70.79% of Haemonetics Corp. stock is owned by institutional investors.

Institutional investors have bought a total of 58.87 M shares in the last 24 months. This purchase volume represents approximately $3.57 B in transactions.